|
NUDT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.48439998865535E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18650000327614E-08 |
| Normal-vs-Stage2 |
1.276000E-03 |
| Normal-vs-Stage3 |
4.988700E-04 |
| Normal-vs-Stage4 |
7.115600E-03 |
| Stage1-vs-Stage2 |
2.832000E-01 |
| Stage1-vs-Stage3 |
2.309200E-01 |
| Stage1-vs-Stage4 |
6.049000E-01 |
| Stage2-vs-Stage3 |
9.813600E-01 |
| Stage2-vs-Stage4 |
7.799200E-01 |
| Stage3-vs-Stage4 |
7.975600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.10259995472961E-09 |
| Normal-vs-AfricanAmerican |
1.221940E-04 |
| Normal-vs-Asian |
6.580200E-02 |
| Caucasian-vs-AfricanAmerican |
2.777000E-01 |
| Caucasian-vs-Asian |
4.526800E-01 |
| AfricanAmerican-vs-Asian |
5.653800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.37630000413603E-08 |
| Normal-vs-Female |
2.597700E-02 |
| Male-vs-Female |
4.87130000004221E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.763370E-04 |
| Normal-vs-Extreme_Weight |
1.58329999999651E-07 |
| Normal-vs-Obese |
1.354040E-04 |
| Normal-vs-Extreme_Obese |
1.346440E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.478400E-02 |
| Normal_Weight-vs-Obese |
7.815000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.927600E-01 |
| Extreme_Weight-vs-Obese |
1.265170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.673400E-01 |
| Obese-vs-Extreme_Obese |
9.739800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.803800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.71819999958711E-07 |
| Normal-vs-Age(61-80Yrs) |
5.7072000458902E-09 |
| Normal-vs-Age(81-100Yrs) |
3.60649999975315E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.323400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.939590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.096100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.007600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.799900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.363150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.5706999973174E-08 |
| Normal-VS-Type2 PRCC |
9.52410000000237E-05 |
| Normal-VS-KIRP CIMP |
4.819200E-01 |
| Normal-VS-Unclassified PRCC |
2.196200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.360500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.430000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.117200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.011040E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.214600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.138400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.27890000051801E-07 |
| Normal-vs-N1 |
4.752200E-02 |
| Normal-vs-N2 |
3.640200E-02 |
| N0-vs-N1 |
1.956230E-02 |
| N0-vs-N2 |
9.693800E-01 |
| N1-vs-N2 |
2.810600E-01 |
|
|
